UBS Group
BDMDW

UBS Group’s Baird Medical Investment Holdings Warrant BDMDW Stock Holding History

UBS Group’s Portfolio BDMDW Stock Details BDMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.86K Hold
48,196
– – ﹤0.01% 9021
2025
Q4 		$2.46K Sell
48,196
-1,327
-3% -$80 ﹤0.01% 9304
2025
Q3 		$3.22K Hold
49,523
– – ﹤0.01% 9071
2025
Q2 		$3.96K Sell
49,523
-864
-2% -$60 ﹤0.01% 9304
2025
Q1 		$3.78K Buy
50,387
+2,191
+5% +$228 ﹤0.01% 9179
2024
Q4 		$9.88K Buy
+48,196
New +$1.91K ﹤0.01% 8333

Other funds holding BDMDW

SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return

UBS Group's BDMDW Position: Q1 2026 in Review

UBS Group held its Baird Medical Investment Holdings Warrant (BDMDW) position steady in Q1 2026 at 48,196 shares worth $3.86K. The position accounts for ﹤0.01% of the portfolio, ranked #9021.

UBS Group first reported a position in BDMDW in Q4 2024 and has held it in 6 quarters since. The position peaked at $9.88K in Q4 2024. 27 funds tracked by Wall St. Rank hold BDMDW as of Q1 2026.

  • UBS Group held 48,196 shares of Baird Medical Investment Holdings Warrant worth $3.86K as of Q1 2026.
  • UBS Group left its Baird Medical Investment Holdings Warrant share count unchanged in Q1 2026.
  • Baird Medical Investment Holdings Warrant made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9021 holding.
  • UBS Group first reported a position in Baird Medical Investment Holdings Warrant in Q4 2024 and has held it in 6 quarters since.
  • UBS Group's Baird Medical Investment Holdings Warrant position peaked at $9.88K in Q4 2024.
  • 27 funds tracked by Wall St. Rank held Baird Medical Investment Holdings Warrant as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.